Ana Collazo

500 total citations
15 papers, 300 citations indexed

About

Ana Collazo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ana Collazo has authored 15 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Ana Collazo's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Ana Collazo is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Ana Collazo collaborates with scholars based in Spain, United States and Italy. Ana Collazo's co-authors include Karin Mellström, Neeraj Garg, Paolo Pevarello, Johan Malm, Antonio Salgado, Bolette Husman, Konrad F. Koehler, Lars-Göran Bladh, Gary J. Grover and Yilin Li and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and BMC Medicine.

In The Last Decade

Ana Collazo

14 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Collazo Spain	8	87	80	71	69	38	15	300
Susan Chippari United States	9	93 1.1×	50 0.6×	138 1.9×	55 0.8×	52 1.4×	14	397
Tadeu L. Montagnoli Brazil	12	127 1.5×	56 0.7×	40 0.6×	71 1.0×	21 0.6×	21	396
Steven G. Wolfe United States	6	94 1.1×	39 0.5×	192 2.7×	39 0.6×	71 1.9×	7	321
Denise M. Wilcox United States	6	128 1.5×	39 0.5×	66 0.9×	110 1.6×	36 0.9×	8	338
Pamela K. Shetler United States	10	148 1.7×	54 0.7×	196 2.8×	210 3.0×	50 1.3×	13	503
Denise Wilcox United States	11	239 2.7×	87 1.1×	74 1.0×	57 0.8×	29 0.8×	18	472
K. Allewaert Belgium	11	109 1.3×	60 0.8×	124 1.7×	37 0.5×	31 0.8×	16	387
Karen M. Zimmerman United States	8	108 1.2×	104 1.3×	15 0.2×	97 1.4×	18 0.5×	11	368
Gabriela Mełeń-Mucha Poland	12	100 1.1×	71 0.9×	50 0.7×	17 0.2×	93 2.4×	28	327
Mohamed D.H. Hassona United States	10	218 2.5×	76 0.9×	89 1.3×	26 0.4×	24 0.6×	13	373

Countries citing papers authored by Ana Collazo

Since Specialization

Citations

This map shows the geographic impact of Ana Collazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Collazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Collazo more than expected).

Fields of papers citing papers by Ana Collazo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Collazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Collazo. The network helps show where Ana Collazo may publish in the future.

Co-authorship network of co-authors of Ana Collazo

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Collazo. A scholar is included among the top collaborators of Ana Collazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Collazo. Ana Collazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Calvo, Virginia, et al.. (2023). Docetaxel as a subsequent line after progression to platinum-based chemotherapy and immunotherapy.. Journal of Clinical Oncology. 41(16_suppl). e21197–e21197. 1 indexed citations

Torrente, María, Pedro Sousa, Virginia Calvo, et al.. (2022). An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study. Cancers. 14(16). 4041–4041. 25 indexed citations

Torrente, María, Pedro Sousa, Fernando Franco, et al.. (2022). Association of quality of life with performance status, circadian rhythm, and activity level of lung cancer patients using wearable devices as ambulatory monitoring. Clinical Medicine. 22(4). 36–37.

Torrente, María, Virginia Calvo, Ana Collazo, et al.. (2022). Risk factors for cardiovascular events in patients treated with immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). e18736–e18736. 1 indexed citations

Remón, Jordi, Fabrizio Tabbò, Beatriz Jiménez, et al.. (2020). Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine. Clinical & Translational Oncology. 22(9). 1425–1429. 5 indexed citations

Madurga, Rodrigo, Noemí Garcia‐Romero, Beatriz Jiménez, et al.. (2020). Normal tissue content impact on the GBM molecular classification. Briefings in Bioinformatics. 22(3). 5 indexed citations

Garcia‐Romero, Noemí, Rodrigo Madurga, Josefa Carrión-Navarro, et al.. (2020). Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. BMC Medicine. 18(1). 142–142. 26 indexed citations

Romero, Atocha, Miguel Ángel Molina‐Vila, Eloísa Jantus‐Lewintre, et al.. (2020). Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial.. Journal of Clinical Oncology. 38(15_suppl). e21518–e21518. 1 indexed citations

Addeo, Alfredo, Giulio Metro, Diego Signorelli, et al.. (2020). Poor performance status and front-line pembrolizumab in advanced non-small-cell lung cancer (NSCLC) patients with PD-L1>50%.. Journal of Clinical Oncology. 38(15_suppl). e21651–e21651. 2 indexed citations

10.

Pérez, Concepción, et al.. (2014). Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross‐sectional study. European Journal of Pain. 19(6). 752–761. 38 indexed citations

11.

Salgado, Antonio, et al.. (2010). Differentiation between [1,2,4]triazolo[1,5‐a] pyrimidine and [1,2,4]triazolo[4,3‐a]‐ pyrimidine regioisomers by ¹H¹⁵N HMBC experiments. Magnetic Resonance in Chemistry. 48(8). 614–622. 27 indexed citations

12.

Salgado, Antonio, Ana Collazo, Fernando Garcı́a, et al.. (2010). Synthesis of [1,2,4]-triazolo[1,5-a]pyrimidines by Dimroth rearrangement of [1,2,4]-triazolo[4,3-a]pyrimidines: A theoretical and NMR study. Journal of Molecular Structure. 987(1-3). 13–24. 21 indexed citations

13.

Garg, Neeraj, Yilin Li, Ana Collazo, et al.. (2007). Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-α-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141. Bioorganic & Medicinal Chemistry Letters. 17(15). 4131–4134. 8 indexed citations

14.

Li, Yilin, Konrad F. Koehler, Karin Mellström, et al.. (2005). Thyroid receptor ligands. Part 4: 4′-amido bioisosteric ligands selective for the thyroid hormone receptor beta. Bioorganic & Medicinal Chemistry Letters. 16(4). 884–886. 20 indexed citations

15.

Liu, Ye, Yilin Li, Karin Mellström, et al.. (2003). Thyroid Receptor Ligands. 1. Agonist Ligands Selective for the Thyroid Receptor β₁. Journal of Medicinal Chemistry. 46(9). 1580–1588. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact